The prevention of glucocorticoid‐induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper

Quentin A. Hill, John Grainger, Jecko Thachil, Drew Provan, Gillian Evans, Mamta Garg, Charlotte Bradbury, Catherine Bagot, John A Kanis, Juliet E Compston, on behalf of the British Society of Haematology in conjunction with the UK ITP forum

Research output: Contribution to journalArticle (Academic Journal)peer-review

3 Citations (Scopus)
84 Downloads (Pure)

Abstract

This Good Practice Paper was compiled according to the British Society for Haematology (BSH) process at http://www.b-s-h.org.uk/guidelines/proposing-and-writing-a-new-bsh-guideline/. The BSH produces Good Practice Papers to recommend good practice in areas where there is a limited evidence base but for which a degree of consensus or uniformity is likely to be beneficial to patient care. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) nomenclature was used to evaluate levels of evidence and to assess the strength of recommendations. The GRADE criteria can be found at http://www.gradeworkinggroup.org.
Original languageEnglish
Pages (from-to)410-417
Number of pages8
JournalBritish Journal of Haematology
Volume185
Issue number3
Early online date4 Jan 2019
DOIs
Publication statusPublished - 1 May 2019

Keywords

  • ITP
  • bisphosphonates
  • corticosteroids
  • immune thrombocytopenia
  • osteoporosis

Fingerprint Dive into the research topics of 'The prevention of glucocorticoid‐induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper'. Together they form a unique fingerprint.

Cite this